• January 18, 2013

    In This Issue:





    SCAI 2013: Fly into Orlando on Tuesday; Soar on Wednesday Morning

    Truly not to be missed, the SCAI 2013 will begin early Wednesday, May 8, and extend to Saturday, May 11, 2013.

    “You really don’t want to miss a minute of this meeting,” says Program Co-chair Morton Kern, MD, FSCAI. “The meeting is bigger and better, starting at the opening gun on Wednesday morning, with unique educational tracks that will fulfill the needs of all interventional cardiologists and help us all become Quality Champions in our field. The bottom line: fly in Tuesday; soar on Wednesday morning.”

    “In addition to the popular, case-based Coronary, Peripheral, Structural, and Congenital Tracks, we’ve developed a new, foundational Quality Track unmatched by any other national meeting in medicine,” says Program Chair Kenneth Rosenfield, MD, FSCAI.

    The Quality Track is a natural extension of Interventional Cardiology’s commitment to quality and optimal patient care and to SCAI’s mission of supporting practitioners in their delivery of quality patient care, data collection, and self-evaluation, adds Dr. Kern. “Attendees will learn the latest news, specifics on how to be a quality and safety champion in the cath lab, and how to stay ahead of the curve in the challenging healthcare climate.” 

    Register Now for SCAI 2013

    Quality is Job #1 - More on the All-new Quality Track at SCAI 2013

    Taking Place in One Easy-to-Navigate Venue - Info on Hotel Accommodations

    Back to Top

    Onsite Registration Still Available for CTO Phoenix on Saturday

    Onsite enrollment will be available for SCAI's CTO Phoenix taking place Saturday at the Hyatt Regency Phoenix. 

    "We're taking an in-depth approach to CTOs," said Program Co-chair David Kandzari, MD, PhD, FSCAI. "With CTOs gaining momentum within the United States, starting a program requires a great deal of planning and insight. Our goal for this program is to arm physicians with the tools and knowledge they need for success while connecting them with a world-class faculty who can answer their questions and help them get started the right way."

    The CTO course will feature basic and advanced information relating to setting up a CTO program, retrograde problem solving, developing a "CTO toolbox," and case-based problem solving. In addition to gaining a stronger understanding of CTO case selection and management, attendees will learn the key decision-making strategies and recognize the hardware necessary for successful case management.

    These one-day training programs will provide interventional cardiologists, fellows-in-training, and cath lab nurses and techs with what they need to know to, focusing on:

    • Procedures;
    • Equipment;
    • Program development;
    • Consent issues;
    • Practical approaches; and
    • Resources for continued education in this area

    Additional Information on CTO Phoenix

    Back to Top

    In the News: SCAI Members Quoted on Hot Topics

    SCAI members, including Secretary James C. Blankenship, MD, FSCAI, Women in Innovations (SCAI-WIN) Chair Roxana Mehran, MD, FSCAI, and Dean Kereiakes, MD, FSCAI, were recently featured in media coverage of topics related to cardiovascular health and treatment.

    Bloomberg wire reporter Michelle Fay Cortez quoted Drs. Blankenship and Kereiakes on how fractional flow reserve will help with clinical decision making, which the article describes as “big change in philosophy that’s moving slowly through the cardiology community.” Of FFR, Dr. Kereiakes  said, “There is physiological evidence that doing the testing is good medicine ... good science, good medicine and cost savings. What more could we ask for?” Also quoted is a patient, Mr. Jack Snyder, who had two blockages, only one of which required a stent. His comment, said Dr. Blankenship, sums up the concerns many patients express when some blockages are left untreated. “I guess I really would have liked to walk out of the hospital with all of the blockages fixed, but I would have to go to college and study heart trouble to say they didn’t do the right thing,” said Mr. Synder. “I do know that I feel great.”

    Meanwhile, Pregnancy Magazine featured Dr. Mehran in a Q&A on data she presented this fall suggesting a link between pregnancy complications, such as preeclampsia and gestational diabetes, and future heart disease. The data come from a pilot project spearheaded by WIN and Abbott’s Women’s Heart Health Initiative, wherein women are screened for heart disease risk factors when they visit their OB/GYNs. The take-home message, said Dr. Mehran, is “take charge of your heart health, know your numbers and be sure to let your physician know if you have a history of a pregnancy complication.”

    Read the Bloomberg Article 

    Read the Article on the Pregnancy Magazine Website

    Download SecondsCount’s “Pregnancy & Your Heart” Info Sheet for Patients

    Back to Top

    SCAI-WIN Launches Multi-Center TAVI Registry in Europe

    In March 2013, SCAI Women in Innovations (SCAI-WIN) will begin collecting registry data on female patients with severe aortic stenosis undergoing TAVI with commercially available valves and delivery systems in Europe. 

    Led by SCAI-WIN Co-chair Alaide Chieffo, MD, FSCAI and Anna Sonia Petronio, MD, the “WIN TAVI Registry” will be a multi-center, prospective, observational registry that will enroll at least 1,000 patients. The goal is to determine the safety and efficacy (according to VARC 2 and BARC definitions) of TAVI in women by way of collecting specific gender-related factors not captured in other registries. These factors include data elements such as history of osteoporosis, gestational diabetes and use of oral contraceptives.

    Collection of gender-specific data will address the lack of sex-based data available for study, a primary reason for the delay in finding real-world solutions to health disparities. TAVI presents an excellent opportunity for collecting data on female patients, typically not well-represented in clinical trials or procedural data, as half of all TAVI procedures are performed on women. The WIN TAVI Registry aims to set a new paradigm for the study of women with heart disease by focusing the registry exclusively on this patient population.

    Additional Details on the WIN TAVI Registry

    Back to Top

    Attending PICS~AICS This Week? Introduce a Colleague to SCAI

    Attending PICS~AICS in Miami this coming week?

    If so, be sure to stop by SCAI's booth (#25) at PICS~AICS and ask any questions you might have about your membership, SCAI initiatives, and the CHD track at SCAI 2013.

    Better yet, this is a great opportunity to introduce colleagues to SCAI and help them learn about the Society's effortsto advance pediatric/congenital interventional cardiology worldwide. Most recently SCAI advocacy efforts with the FDA led to the involvement of pediatric/congenital interventionalists in the development of the ASD Occluder post-market surveillance study and release of a $2 million federal grant testing for bioabsorbable stents for coarctation. More work is required for these priorities and more. Encourage your colleagues at PICS~AICS to join us by by applying to become a Fellow of SCAI (FSCAI).

    Additionally, SCAI will be offering attendees special on-site discounts.

    See YOU in Miami!

    Back to Top

    Call for Nominations to SCAI Board of Trustees & Executive Committee

    SCAI is seeking nominations for the Board of Trustees (BOT) and other positions.

    PROCEDURE: SCAI encourages all members to send nominations to the Nominating Committee for consideration. You can nominate any SCAI Fellow (FSCAI) in good standing (including yourself if you wish). The Nominating Committee will then forward its recommendations to the BOT informationally, and to SCAI Fellows, Senior Fellows and Emeritus Fellows prior to the SCAI 2013 Scientific Sessions this May in Orlando. All Fellows, Senior Fellows and Emeritus Fellows present at the SCAI Annual Business Meeting in Orlando will vote on these recommendations. Nominations from the floor will also be accepted during the business meeting.

    POSITIONS:  Nominations are solicited for the following positions:

    Trustee:  Seven slots, for the term May 2013 – May 2016

    Secretary:  One slot (member of the Executive Committee), for the term May 2013 – May 2014

    Assistant Treasurer:  One slot, for the term May 2013 – May 2014

    At-large Member of the Nominating Committee:  One slot, for the term May 2013 – May 2016

    This year's Nominating Committee consists of:

    Larry Dean, MD, FSCAI (Nominations Chair and Past President)

    Christopher J. White, MD, FSCAI (Nominations Co-chair and Immediate Past President)

    J. Jeffrey Marshall, MD, FSCAI (President)

    Ashok Seth, MD, FSCAI (at-large Nominating Committee member, May 2012 – May 2015)

    Thomas Jones, MD, FSCAI (at-large Nominating Committee member, May 2011 – May 2014)

    Alexandre Abizaid, MD, PhD, FSCAI (at-large Nominating Committee member, May 2011- May 2013)

    COMMITMENT: The BOT meets in person a minimum of three times a year; the Executive Committee (EC) meets twice monthly by conference call. Members of the BOT and EC are expected to attend all such meetings. Other communications (conference calls, list serve, etc) and meetings are scheduled as events warrant.

    ELIGIBILITY: Any Fellow (FSCAI) may be nominated to serve. If you would like to nominate someone, simply send an email with the person's name and your name to SCAI Executive Director Norm Linsky at nlinsky@scai.org and to Nominations Chair Dr. Larry Dean (lsdean@u.washington.edu). All nominations must be received by Friday, February 8, 2013. Thank you!

    Back to Top